← Product Code [GXI](/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/GXI) · K063467 # SMITH & NEPHEW RF CANNULAE (K063467) _Smith & Nephew, Inc. · GXI · Nov 21, 2006 · Neurology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/GXI/K063467 ## Device Facts - **Applicant:** Smith & Nephew, Inc. - **Product Code:** [GXI](/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/GXI.md) - **Decision Date:** Nov 21, 2006 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 882.4725 - **Device Class:** Class 2 - **Review Panel:** Neurology - **Attributes:** Therapeutic ## Indications for Use Smith & Nephew RF Cannulae are intended to facilitate placement of Smith & Nephew RF Denervation Probes. The Smith & Nephew RF Cannulae are indicated for use in RF heat lesion procedures for the relief of pain. ## Device Story Smith & Nephew RF Cannulae are sterile, single-use devices designed to facilitate the placement of RF Denervation Probes. Used in conjunction with the Smith & Nephew Electrothermal 20S Spine System Generator, the cannulae provide a pathway for the probe to reach the target tissue. The system is used by clinicians in RF heat lesion procedures to provide pain relief. The device functions as a mechanical guide for the temperature-sensing electrode, which delivers radiofrequency energy to create lesions. ## Clinical Evidence Bench testing only. The device meets electrical safety requirements for UL 60601-1 and IEC 60601-1 when used with the Smith & Nephew Electrothermal 20S Spine System Generator. ## Technological Characteristics Radiofrequency lesion probe cannula; sterile, single-use; compatible with Smith & Nephew Electrothermal 20S Spine System Generator; electrical safety per UL 60601-1 and IEC 60601-1. ## Regulatory Identification A radiofrequency lesion probe is a device connected to a radiofrequency (RF) lesion generator to deliver the RF energy to the site within the nervous system where a lesion is desired. ## Predicate Devices - Smith & Nephew RF Probe and Cannulae ([K034012](/device/K034012.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Endoscopy Smith & Nephew, Inc 150 Minuteman Road Andover, MA 01810 smith-nephew.com - We are smith&nephew Page 1 of 2 K063467 2006 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION a required by the Safe Medical Devices Act of 1990 and codified in 21 CFR 807.92 upon which the substantial equivalence is based. ### Smith & Nephew RF Cannulae Date Prepared: October 20, 2006 #### A. Submitter's Name: Smith & Nephew, Inc., Endoscopy Division 150 Minuteman Road Andover, MA 01810 #### B. Company Contact Minnie Mildwoff Regulatory Affairs Specialist 978-7491538 (phone), 978-7491443 (fax) # C. Device Name | Trade Name: | Smith & Nephew RF Cannulae | |----------------------|------------------------------| | Common Name: | Probe, Radiofrequency Lesion | | Classification Name: | Radiofrequency Lesion Probe | # D. Predicate Devices The Smith & Nephew RF Cannulae is substantially equivalent in Intended Use and Fundamental Scientific Technology to the following legally marketed device in commercial distribution: Smith & Nephew RF Probe and Cannulae (K034012). #### E. Description of Device The Smith & Nephew RF Denervation Probe is a temperature sensing electrode designed for use in radiofrequency lesion procedures. The RF Denervation Probe is used with a disposable Smith & Nephew RF Cannula. Smith & Nephew RF Cannulae are offered in a variety of sizes and tip configurations. The RF Cannulae are packaged sterile for single use. #### F. Intended Use Smith & Nephew RF Cannulae are intended to facilitate placement of Smith & Nephew RF Denervation Probes. The Smith & Nephew RF Cannulae are indicated for use in RF heat lesion procedures for the relief of pain. {1}------------------------------------------------ K 063 467 Image /page/1/Picture/1 description: The image shows the text "Page 2 of 2" in a handwritten style. Below the page number is the text "We are smith&nephew" in a bold font. There is a star-like symbol to the left of the text "We are smith&nephew". # G. Comparison of Technological Characteristics The Smith & Nephew RF Denervation Probes & RF Cannulae are substantially equivalent in design, materials, function and intended use to the following device cleared for commercial distribution: ﮯ۔ Smith & Nephew RF Probes and Cannulae - K034012 ### H. Summary Performance Data The Smith & Nephew RF Denervation Probes & RF Canulae meet the requirements of electrical safety standards for UL 60601-1 and IEC 60601-1 when used in combination with the Smith & Nephew Electrothermal® 20S Spine System Generator. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the department's name around the perimeter. In the center of the seal is a stylized image of an eagle. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Smith & Nephew, Inc. % Ms. Minnie Mildwoff, RAC Regulator Affairs Specialist Endoscopy Division 150 Minuteman Road Andover, Massachusetts 01810 NOV 2 1 2006 Re: K063467 Trade/Device Name: Smith and Nephew RF Cannulae Regulation Number: 21 CFR 882.4725 Regulation Name: Radiofrequency lesion probe Regulatory Class: II Product Code: GXI, GXD Dated: October 23, 2006 Received: October 24, 2006 Dear Ms. Mildwoff: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {3}------------------------------------------------ Page 2 - Ms. Minnie Mildwoff, RAC This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilitics under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Rola Palph Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Indications for Use 510(k) Number (if known): K063467 Device Name: Smith and Nephew RF Cannulae Indications For Use: Smith & Nephew RF Cannulae are intended to facilitate placement of Smith & Nephew RF Denervation Probes. The Smith & Nephew RF Cannulae are indicated for use in RF heat lesion procedures for the relief of pain. Prescription Use X (Per 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Pto Rhen avision of G and Neurologi 12063467 5106 510/k Vir Smith & Nephew, Inc RF Cannulae Page 15 of 67 --- **Source:** [https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/GXI/K063467](https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/GXI/K063467) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com